Insulin resistance and diminished insulin secretion are key characteristics of the progression to type 2 diabetes [3], and are often used as outcomes in intervention trials aimed at preventing the development of type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.